Log In
Print this Print this

tegobuvir (GS 9190, GS-9190)

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionNon-nucleoside HCV NS5B polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV genotype 1 infection in treatment-naïve patients; Treat HCV genotype 1 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today